ACTU Actuate Therapeutics, Inc. Common stock

track record → $2.88 -0.02 (-0.7%)
Get emailed when ACTU changes direction
Mkt Cap $70M 52wk $1.58 - $11.99 Earnings 2026-05-15
Factor Model (net +3.1)

Factor Model

net +3.1
Est. Revisions
+0.8
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

6h ago Short interest surged 40% to 914,989 shares
8d ago HC Wainwright & Co. reit ACTU: Buy → Buy
14d ago Insider buy by BIOS EQUITY COF, LP (ACTU): $499,996
14d ago Insider buy by BIOS EQUITY COF, LP (ACTU): $4,000,000
Fundamentals & Data ▾
Actuate Therapeutics, Inc. Common stock Healthcare · Biotechnology
Mkt Cap
$70M
52w Range
$1.58 - $11.99
Short Interest
914,989 8.92%
Days to Cover
7.0 +37%
Technicals downtrend
from 52w Hi
-3.0%
1w return
+3.6%
Insiders
selling 2B / 3S
Analysts
mixed
EPS Estimate
$-0.21 +17.0% 30d 2up / 0dn
Est. Dispersion
29% 4 analysts
Analyst Target
$14 $6 - $25
Insider Cluster
sell cluster 1B / 2S
Recent Filings & Data
insider trade 8
net buying · $1,973,992 sold · $4,499,996 bought
3 insiders · 8 transactions (30d)
Recent transactions
BIOS EQUITY COF, LP · exercise · $200,002
SCHMITT DANIEL M. · other
THOMSON TODD S. · sell · $1,624,000
BIOS EQUITY COF, LP · buy · $499,996
THOMSON TODD S. · sell · $150,000
THOMSON TODD S. · other
BIOS EQUITY COF, LP · buy · $4,000,000
BIOS EQUITY COF, LP · sell · $199,992
5 signals · latest 6h ago

Get alerted when ACTU changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.